Deutsche Bank’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KYTX
ACM
Deutsche Bank's KYTX Position: Q3 2026 in Review
Deutsche Bank reduced its Kyverna Therapeutics (KYTX) stake by 11% in Q3 2026, selling an estimated $40.4K and leaving 39,736 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.
Deutsche Bank first reported a position in KYTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $400K in Q2 2026. 128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.
- Deutsche Bank held 39,736 shares of Kyverna Therapeutics worth $270K as of Q3 2026.
- Deutsche Bank sold 5,117 Kyverna Therapeutics shares in Q3 2026, an estimated $40.4K.
- Kyverna Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2941 holding.
- Deutsche Bank first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 7 quarters since.
- Deutsche Bank's Kyverna Therapeutics position peaked at $400K in Q2 2026.
- 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.